RETN mAb (BGD9) BC-1 B Cell Engineering Cassette (CAT#: BGS-0624-CR836)

This product is a BC-1 B cell engineering tool based on the Nanoparticles (SS-Fc/Carcinoembryonic antigen) delivery system and CRISPR-based (hROSA26-huIgH296-SpCas9-(Z)-4-Hydroxytamoxifen) genome editor.

Datasheet

Specifications

Host Cell BC-1
Target RETN
Insert Clone BGD9
Safe Harbor Sites (SHS) hROSA26
gRNA huIgH296
Nuclease SpCas9
Enhancer (Z)-4-Hydroxytamoxifen
Targeting Strategy Enzyme responsive
Insertion sites Unproductive heavy chain
Vehicles Nanoparticles
Ligand/Receptor SS-Fc/Carcinoembryonic antigen
Active Agents [Ru(bpy)2(tip)]2+, RBT
Particle Size 41-150
Charge (mv) 11 to 77
Total Atom Count -61000000
Surface Atoms (%) -0.7
Specific Surface Area (m2/g) -3.6
Vector Type MSCV
Vector Name BCpCDH6
Targeting Diseases Pancreatic cancer; Ovarian cancer; Breast cancer; Colon cancer; Melanoma
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products